Industry News & Regulations

The nicotine pouch industry is getting more complex by the day, as new brands launch and vie for dominance. For those who really want to understand this landscape, it’s a must to get some intel about which companies are on the up and which are facing some turbulence. While we’re a nicotine pouch retailer ourselves, there’s nothing like having a nosy look at the rest of the industry.

This report breaks down the latest financial results of the main companies in the industry, including ZYN’s Philip Morris International and VELO’s British American Tobacco. We’ll also run through some other recent developments in the market.

The U.S. Food and Drug Administration (FDA) has given the core ZYN collection a modified risk granted order. As a result, manufacturer Swedish Match can market ZYNs as being lower-risk than tobacco products. The FDA issued this authorization on 30 June, 2026, and it applies to ZYN products with nicotine strengths of 3mg or 6mg.

In this article, we’ll break down what modified risk tobacco products are, explain what the decision really means, and outline the difference between modified risk tobacco products and other regulation categories. Don’t be scared by the jargon — this is all simpler than it sounds!

With the world of nicotine pouch legislation changing so fast in the US, it’s only natural to wonder what’s coming next. While nobody can give a truly satisfying answer to that until the relevant policies are all but passed, other countries provide an interesting point of comparison. Given that in some parts of the world, nicotine pouches are legally classified as poison, it will be a relief to some that global legislation isn’t a roadmap for the US — different nations have vastly different political and social contexts.

The U.S. Food and Drug Administration (FDA) announced in May 2026 that it would be easing restrictions on unauthorized nicotine products, including flavored nicotine pouches and e-cigarettes. This represents a significant change from its previous policy, which required companies to undergo lengthy, rigorous reviews before they were available in the market.

Few industries experience as much regulatory scrutiny as tobacco, which is why the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) is known for being one of the most embraced in the whole of the United Nations. COP11 provided an opportunity for entities across the globe to meet and discuss this framework.

This is a topic worth following for any nicotine pouch users hoping to be on top of what’s happening in the legislative world, and this guide runs through the main topics discussed at the conference. They include environmental sustainability, marketing, and how new nicotine pouches should be treated.

Those interested may also enjoy reading our takeaways from the Global Tobacco & Nicotine Forum 2025.

On January 1, 2026, a new wave of nicotine product regulations came into effect across the United States. Since then, lawmakers have continued introducing new restrictions on nicotine pouches and other smoke-free products, with proposals ranging from flavor bans and tax increases to sales and shipping restrictions.

Because nicotine pouch regulations can vary significantly between states—and are often subject to change—staying informed isn't always easy. That's why we've created this regularly updated guide, tracking the latest federal and state-level developments that may affect nicotine pouch users across the country.

The more popular nicotine pouches become, the more responsible both manufacturers and users must be. One area that has been increasingly receiving attention is the packaging manufacturers use, as this impacts how easily children can open pouch cans. The FDA has urged manufacturers to take measures to reduce the probability of this happening, and it’s likely to continue to be a relevant topic.

This article breaks down the meaning of the announcement, possible directions that future legislation can take, and the role users themselves can play in protecting public health.

The fast growth of the nicotine pouch market has led to a regulation crisis, with brands entering the market and seeking approval faster than the U.S. Food and Drug Administration (FDA) can decide whether to authorize them.

Pouch users might typically care more about getting their hands on their product of choice than understanding the complex regulations behind them. But with recent developments, like the pilot program to fast-track pouch approval, it's natural to have a little curiosity.

This article runs through the basics of nicotine pouch regulation, including the difference between PMTAs and MGOs.

With the regulatory landscape changing so fast in the nicotine pouch world, it’s more important than ever for major players to learn from each other. The Trump Administration and state governments are continuing to make significant changes to nicotine legislation, many of which we outlined in our regulatory roundup 2025. Across the world, other countries are experiencing the same.

The Global Tobacco & Nicotine Forum exists so discussions about these kinds of regulations can take place, and the latest event took place in October 2025. This article summarizes the main themes and takeaways in relation to nicotine pouches, which have relevance for brands, retailers, and consumers alike.

Nothing strikes fear into the heart of nicotine pouch manufacturers quite like hearing there’s been a change in regulations. When it comes to tax hikes, this news can also be a source of terror for users. But here in the US, these changes have become unescapable. 2025 has been a year with plenty of change, and it can be hard to keep up — but Prilla has everyone covered.